RE:RE:RE:a second formulation of avenanthramides pillsUSED PROPHYLATIC This is what you quoted initially, not the partial edited garbage you just wrote.
"Clinical Trial:
Subsequent to quarter, the Company received an Acknowledgement Letter from Health Canada confirming complete information and material to support a Clinical Trial Application (CTA) for Phase 1/2a study entitled “Ceapro Inc Avenanthramide (AVA): A Double-Blind, Placebo-Controlled, Randomized, Adaptive, First-in-Human Study to Assess Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of Avenanthramide (AvenActive).” A response from Health Canada for clearance to proceed with this study is expected to be received within 90 days."
NOTE subsequent to the quarter and expected to receive clearence within 90days.
Well 90days are up you idiot where is the news release?